Newscenter Media News Oxford begins first human trial of new Lassa Fever vaccine
By Abujah Racheal The global fight against Lassa fever has recorded another breakthrough as the Oxford Vaccine Group administered the first dose of a new Lassa fever vaccine to a volunteer in the United Kingdom. The event, announced online on Thursday, took place in Oxford through the Oxford Vaccine Group,
